Navigation Links
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
Date:10/24/2007

, safety, tolerability and food effect of R7128 in healthy volunteers and in patients chronically infected with HCV genotype 1. This adaptive Phase 1 study is comprised of three parts:

Part 1 is a single ascending dose study of R7128 conducted in 46 healthy volunteers. The primary objective of Part 1 is to assess the safety, tolerability and pharmacokinetics of R7128 following single ascending doses under fasting conditions. The secondary objective of Part 1 is to explore the effect of food on the pharmacokinetics of R7128. Results from the single ascending dose portion of the study indicated that all doses of R7128 studied (500 mg to 9000 mg) were generally safe and well-tolerated. All patients completed the study, and none experienced gastrointestinal adverse events or serious adverse events during the study. No hematological or laboratory abnormalities of clinical significance were noted.

Part 2 is a multiple ascending dose study of R7128 conducted in 40 patients chronically-infected with HCV genotype 1 who previously failed interferon therapy. The primary objective of Part 2 is to assess the safety, tolerability and pharmacokinetics of R7128 after once-daily (QD) or twice- daily (BID) dosing for 14 days. The secondary objective is to assess antiviral activity by measuring the change in HCV RNA. Preliminary data from the multiple ascending dose portion of the study indicated that R7128 demonstrated potent, dose-dependent antiviral activity in four patient cohorts receiving 750 mg or 1500 mg administered either once-daily or twice-daily for 14 days as monotherapy. Patients receiving 1500 mg BID demonstrated a mean 2.7 log10 IU/mL (>99%) decrease in HCV RNA. There was no evidence of viral rebound in any dose cohort during the 14 days of dosing. R7128 was generally safe and well tolerated. There were no serious adverse events, no adverse events requiring dose modification, no dose-related gastrointestinal adverse events and no clinically significant chan
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
3. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
4. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
5. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
6. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
7. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
8. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
9. Staphylococcus aureus vaccine development on track ? safe and immunogenic in Phase I clinicaltrials
10. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
11. Point of Care Strep Tests Speed Treatment, Lower Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015 According ... & Cardiac Rhythm Management Market ECG, Implantable Loop ... Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P ... the global Cardiac Monitoring (CM) and Cardiac Rhythm ... $26,646.5 Million by 2020 from $21,137.7 Million in ...
(Date:7/3/2015)... , July 3, 2015 A ... of hypertension, diabetes and thyroid disorders in ... and a major conference dedicated to these diseases. ... Diabetes Online , Manage Hypertension Online and ... operated by EXCEMED - combine the world,s ...
(Date:7/3/2015)... July 3, 2015  Obsidian HDS, the developer of ... service for the management of data on pharmaceutical and ... PharmaShine now includes the 2014 Open Payments General and ... on June 30. The data disclosed on Open Payments ... industry and providers totaling $6.49 billion and is the ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... WAUKESHA, Wis., Sept. 29 MedPro Imaging, a premier ... of its Ultrasound Transducer Repair Division.  Based on proprietary ... MedPro Imaging will offer high quality computer-based transducer repair ... industry on probe exchange programs. "The industry ...
... 29 Crosstex International, a subsidiary of ... today the publication of sponsored research that suggests a ... commonly referred to as surgical masks, than previously understood. ... mask or respirator is most effective when worn by ...
Cached Medicine Technology:MedPro Imaging Launches Ultrasound Transducer Repair Division 2New Mask Study Supports CDC's Updated Guidance for Seasonal Flu Prevention Strategies 2New Mask Study Supports CDC's Updated Guidance for Seasonal Flu Prevention Strategies 3
(Date:7/3/2015)... (PRWEB) , ... July 04, 2015 , ... The Harvest Hope Food Bank ... July. Four local AlignLife offices in the area of Greenville SC are making ... to be made by patients only. They are asking for donations from the public as ...
(Date:7/3/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. ... To be held from March 4th - 6th, the 2016 (a previous announcement had ... , Designed to take participants from the basic training and fundamentals of nasal surgery ...
(Date:7/3/2015)... ... 03, 2015 , ... Talcum powder attorneys representing clients in national lawsuits announce ... Lawsuit Center website. Just as the previous version did, the new website will serve ... updates and ovarian cancer warning information. The site is routinely updated with news articles ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Every year, One-to-1 ... Train-a-Thon where they provide members of the Red Deer community with free fitness training ... of fitness training, games, food, events and entertainment raised thousands of charity dollars and ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on June 22, ... emphatically declared a war on obesity in the United States. , "Obesity is one ... the magnitude of this discovery. For that reason, I am declaring, along with my ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... launched its approved generic formulation of clarithromycin// immediate ... press release. Ranbaxy has been given the green ... and 500 mg under the Ranbaxy label. Clarithromycin ... to moderate infections caused by susceptible strains of ...
... of California-San Francisco has published that weight loss// supplements ... increasing heart beat rate and blood pressure. It ... ,The study spearheaded by Dr. Christine A. Haller ... group of 16 healthy adults. Two tests were performed ...
... mutation of the gene involved in causing// the condition ... from Yale School of Medicine have reported in their ... for sodium channel Nav1.7 is responsible for people to ... have studied the DNA samples from 36 members of ...
... smoking during pregnancy is associated with reduced birthweight// and ... associated with several problems in the newborn. ... and spouses' expired air carbon monoxide (CO) concentrations (EACO) ... monoxide (CO) concentrations (EACO) is a measure of smoking ...
... Mannheim, concludes that women appear to develop alcoholic brain damage ... become dependant on alcohol not as frequently as men do. ... general alcohol consumption pattern if men and women. Therefore it ... pregnancy. It might have adverse effects on the child as ...
... Lorenzos oil can prevent the spread of a form of ... from Kennedy Krieger Institute in Baltimore have reported that use ... X-ALD in boys aged 7 years and younger who were ... doses of the oil, which is a composite mixture of ...
Cached Medicine News:
Rhoton Curettes, titanium, length 191 mm, straight....
Temporary...
Barraquer needle holder, curved, delicate....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medicine Products: